ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2018 ACR/ARHP Annual Meeting

October 19-24, 2018 in Chicago, IL

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
  • Abstract Number: 413
    S100A8 & S100A9: Alarmin Mediated Inflammation in Tendinopathy
  • Abstract Number: 1872
    Safety and Efficacy of Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus: Results of an Open-Label Phase I Study
  • Abstract Number: L06
    Safety and Efficacy of Filgotinib in a Phase 3 Trial of Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Biologic Dmards
  • Abstract Number: 1715
    Safety and Efficacy of Lenabasum in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects
  • Abstract Number: 2284
    Safety and Efficacy of Lenabasum in Refractory Skin-Predominant Dermatomyositis Subjects Treated on an Open-Label Extension of Trial JBT101-DM-001
  • Abstract Number: 2565
    Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Third Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
  • Abstract Number: 2892
    Safety and Immune Response of a Live Attenuated Herpes Zoster Vaccine in Patients with Systemic Lupus Erythematosus (SLE): A Randomized Placebo-Controlled Trial
  • Abstract Number: 791
    Safety and Suitability of a Direct Thrombin Inhibitor, Dabigatran Etexilate, in Scleroderma-Associated Interstitial Lung Disease (SSc-ILD) Patients
  • Abstract Number: 1539
    Safety of Methotrexate and Leflunomide Combination Therapy in the Treatment of Rheumatoid Arthritis
  • Abstract Number: 1413
    Safety of Tocilizumab in Patients Aged <2 Years with Active Systemic Juvenile Idiopathic Arthritis Treated for One Year
  • Abstract Number: 2191
    Safety of Ultrasound-Guided Injections Using Local Puncture Site Sterility
  • Abstract Number: 962
    Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 6 Years: An Updated Integrated Safety Analysis
  • Abstract Number: 2219
    Safety, Pharmacokinetics and Pharmacodynamics of NC-2500, a Novel Xanthine Oxidoreductase Inhibitor, in Healthy Volunteers
  • Abstract Number: 2535
    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CKD-506, a Novel, Histone Deacetylase 6 (HDAC6) Inhibitor, in Healthy Volunteers
  • Abstract Number: 1573
    Salivary Dysbiosis Correlates with Clinical Status of Anti-Ro Positive Mothers of Children with Neonatal Lupus
  • Abstract Number: 1572
    Salivary Flow Rates and Oral Health Related Quality of Life Are Associated with Ultrasonographic Scoring of the Major Salivary Glands in Sjogren Syndrome
  • Abstract Number: 1783
    Salivary Gland Disease in IgG4-Related Disease Is Associated with Allergic Histories
  • Abstract Number: 360
    Sarcoidosis Induced By Immune Check Point Inhibitors
  • Abstract Number: 2539
    SB4 Shows Comparable Short-Term Effectiveness to Its Etanercept Originator As First-Line Biologic Treatment for Patients with Rheumatoid Arthritis in Routine Clinical Care
  • Abstract Number: 2707
    Scleroderma Renal Crisis: The Association of High-Dose Steroids and Poor Outcome
  • Abstract Number: 1225
    Screening for Acquired Latent Tuberculosis in Patients with Rheumatoid Arthritis(RA) on Anti-Tnfα Therapy (TNF-I) in Southern California
  • Abstract Number: 1252
    Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience
  • Abstract Number: 2790
    Screening of Patients with Adult-Onset Idiopathic Polyarteritis Nodosa for Deficiency of Adenosine Deaminase 2
  • Abstract Number: 1847
    Screening Youth with Lupus for Depression and Anxiety in Pediatric Rheumatology Clinics
  • Abstract Number: 465
    Seasonal Variation in Cutaneous Flares for Pediatric Lupus
  • Abstract Number: 2766
    Seasonal Variation in Incidence of Giant Cell Arteritis: A Population-Based Cohort Study
  • Abstract Number: 2168
    Seasonal Variation in Incidence of Polymyalgia Rheumatica: A Population-Based
  • Abstract Number: 2556
    Secukinumab 150mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis with Consistent Safety Profile and High Retention Rate: 4-Year Results from a Phase III Trial
  • Abstract Number: 2564
    Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients
  • Abstract Number: 2585
    Secukinumab Immunogenicity in Patients with Psoriatic Arthritis and Ankylosing Spondylitis during a 52-Week Treatment Period
  • Abstract Number: 2562
    Secukinumab Improves Grappa-Omeract Core Domains of Psoriatic Arthritis
  • Abstract Number: 2386
    Secukinumab Is a Promising Treatment for Patients with Juvenile Enthesitis Related Arthritis Nonresponsive to Anti-TNF Treatment
  • Abstract Number: 2583
    Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Ankylosing Spondylitis: A Pooled Analysis from the Secukinumab Phase 3 Trial Program
  • Abstract Number: 2553
    Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Psoriatic Arthritis: Pooled Results from the Secukinumab Phase 3 Trial Program
  • Abstract Number: 2886
    Secukinumab Provides Rapid and Sustained Resolution of Enthesitis in Psoriatic Arthritis Patients: Pooled Analysis of Two Phase 3 Studies
  • Abstract Number: 2568
    Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial
  • Abstract Number: 2608
    Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: Long-Term (4-Year) Data from a Phase 3 Study
  • Abstract Number: 1189
    Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean Perspective
  • Abstract Number: 936
    Selective Deficiency of Serine Arginine-Rich Splicing Factor 1 (SRSF1) in T Lymphocytes Leads to mTORC1 Activation, Treg Dysfunction and Systemic Autoimmune Disease
  • Abstract Number: 2683
    Selective Expansion and Targeting of FoxP3+CD127lo Regulatory T Cells By Low-Dose IL-2 Therapy in Active SLE
  • Abstract Number: 2174
    Self-Report of Fracture History Compared to Fracture Codes from an Electronic Health Record Dataset
  • Abstract Number: 1950
    Self-Reported Depression and Anxiety Among US Adults Aged 18-44 Years with Arthritis, National Health Interview Survey 2014-2016
  • Abstract Number: 489
    Self-Reported Depression in Patients with Rheumatoid Arthritis Is Undertreated and Associated with Poorer Clinical Status and Lower Rates of Remission in Routine Care
  • Abstract Number: 715
    Septic Shock Among Patients with Systemic Lupus Erythematosus: Short and Long-Term Outcome and Cost. Analysis of the French Nationwide Database
  • Abstract Number: 1976
    Sequencing of the MHC Region Defines HLA-DQA1 As Driven Risk for Anti-Citrullinated Protein Antibodies (ACPA)-Positive Rheumatoid Arthritis in Han Population
  • Abstract Number: 1091
    Serine Arginine-Rich Splicing Factor 1 (SRSF1) Is Essential for T Lymphocyte Homeostasis and Decreased Levels of SRSF1 Correlate with Lymphopenia in SLE Patients
  • Abstract Number: 1637
    Serious Infections Among Psoriatic Arthritis Patients Taking TNF Inhibitors Versus Non-TNF Biologics: A Systematic Review and Network Meta-Analysis
  • Abstract Number: 1093
    Serologic Evidence Linking Epstein Barr Virus Reactivation, Heightened Interferon Pathway Activation and Increased Disease Activity in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1221
    Serologic Screening for Coccidioidomycosis Among Medicare Beneficiaries with Rheumatic Diseases on Biologic Response Modifiers, Corticosteroids, and Dmards
  • Abstract Number: 1070
    Seroreactivity Against Recombinant Citrullinated Myosin Is Associated with Measures of Diastolic Dysfunction in Patients with Rheumatoid Arthritis
  • Abstract Number: 2266
    Serum 1,25(OH)2 Vitamin D and 25(OH) Vitamin D Ratio for the Diagnosis of Sarcoidosis-Related Uveitis
  • Abstract Number: 735
    Serum Albumin at One Year Predicts Long-Term Renal Outcome
  • Abstract Number: 1477
    Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. a Simulation Study in the United States of America
  • Abstract Number: 1680
    Serum Calprotectin in Systemic Lupus Erythematosus: Is It a Good Activity Biomarker?
  • Abstract Number: 172
    Serum Chemokines and miRNA Levels and Its Association with Cumulative Organ Damage in Patients with Antiphospholipid Syndrome: A Bench to Bedside Study
  • Abstract Number: 1708
    Serum Complement Regulatory Proteins and Disease Activity of Systemic Lupus Erythematosus
  • Abstract Number: 880
    Serum Cytokine and Chemokine Concentrations Predict Incident Cancer in US Veterans with Rheumatoid Arthritis
  • Abstract Number: 2121
    Serum High Type I Interferon Is Associated with Active Proliferative Lupus Nephritis in Lupus Patients Accompanied with High Interferon Signature Gene Expression and Plasmacytoid Dendritic Cell Infiltration in Lupus Nephritis Kidney
  • Abstract Number: 1784
    Serum IgG4 Test Characteristics: Immunonephelometry Versus Liquid Chromatography Tandem Mass Spectrometry
  • Abstract Number: 2066
    Serum IL-37 Is an Efficient Biomarker of Disease Activity and Treatment Response in Patients with Ankylosing Spondylitis
  • Abstract Number: 2046
    Serum Immunoglobulin G Targets Citrulline-Containing Immunoglobulin G Peptides in Rheumatoid Arthritis Patients Who Test Positive for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies
  • Abstract Number: 905
    Serum Interleukin-6 Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 877
    Serum Krebs Von Den Lungen-6 Is a Useful Biomarker for Assessing Activity of Myositis-Associated Interstitial Lung Disease
  • Abstract Number: 2041
    Serum Level of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1): A New Biomarker of Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 2880
    Serum Levels of Thymic Stromal Lymphopoietin: A Possible Novel Biomarker in Primary Sjögren’s Syndrome and Related Lymphoproliferation
  • Abstract Number: 1743
    Serum Markers Potentially Associated with PAH in Systemic Sclerosis; A Targeted Screening Approach
  • Abstract Number: 1061
    Serum Metabolomic Profiling Predicts Synovial Gene Expression in Rheumatoid Arthritis
  • Abstract Number: 1498
    Serum MMP-3 More Than 155ng/Ml at Baseline Predicts One-Year Radiographic Progression in Patients with Rheumatoid Arthritis
  • Abstract Number: 2252
    Serum Urate Ant Its Clearance in Patients with Chronic Kidney Disease Under Peritoneal Dialysis
  • Abstract Number: 2230
    Serum Urate Levels in People with Gout on Dialysis – Are We Achieving Treatment Targets?
  • Abstract Number: 2672
    Serum Vitamin D Levels and Its Effect on Disease Activity and Fatigue in Systemic Lupus Erythematosus Patients
  • Abstract Number: 2904
    Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients and Healthy Controls
  • Abstract Number: 341
    Setting Treatment Target for Joint Surgery in Lower Limbs in Patients with Long-Standing Rheumatoid Arthritis Based on Multicenter Prospective Cohort Study; Validation and Reliability of Objective Index of Activity Speed (Timed Up and Go test) for Measuring Physical Function
  • Abstract Number: 390
    Severe Axial and Pelvifemoral Muscle Damage in Immune-Mediated Necrotizing Myopathy Evaluated By Whole-Body MRI
  • Abstract Number: 2726
    Severe Infections in Systemic Necrotizing Vasculitis: Incidence and Risk Factors
  • Abstract Number: 1564
    Severe, Life-Threatening Phenotype of Primary Sjögren Syndrome: Clinical Characterization and Outcomes in 1580 Patients (GEAS-SS Registry)
  • Abstract Number: 2243
    Sex Difference of the Association between Serum Urate and Blood Pressure in Young Adults
  • Abstract Number: 1496
    Sex Differences in the Achievement of Clinical Remission and Low MRI Synovitis Scores in Rheumatoid Arthritis
  • Abstract Number: 2495
    Sex Differences in the Achievement of Remission in Rheumatoid Arthritis – Choice of Disease Activity Measure Matters
  • Abstract Number: 2325
    Sex Differences in the Association of Frailty and Bone Mineral Density in Patients with Rheumatoid Arthritis
  • Abstract Number: 2796
    Sex-Based Differences Control ABC Function in Swef-Deficient Mice
  • Abstract Number: 1170
    Sex-Specific Associations between Systemic Inflammatory Cytokines and Osteoarthritis Knee Pain
  • Abstract Number: 108
    Sex-Specific Expression of CXorf21 Provide Molecular Explanation for the Fundamental Difference in Male and Female Immune Response: An Explanation for Female-Bias SLE Pathogenesis
  • Abstract Number: 2365
    Sex, Language and Age of Disease Onset Impact Illness Perceptions Among RA Patients
  • Abstract Number: 385
    Sexual Dysfunction in Female Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 1726
    Sexual Dysfunction in Systemic Sclerosis Female Patients
  • Abstract Number: 810
    Sexual Dysfunction in Women with Systemic Sclerosis
  • Abstract Number: 13
    Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies
  • Abstract Number: 1780
    Shear Wave Elastography in the Evaluation of Submandibular Gland Characteristics in IgG4-Related Disease
  • Abstract Number: 262
    Shedding Light on Fibromyalgia: Emotional Regulation Processes and Executive Functions Join Together
  • Abstract Number: 5
    Short Chain Fatty Acid Acetate Induces Regulatory B Cells in Mice and Humans, Which Can Protect Against Arthritis
  • Abstract Number: 946
    Short-Term Safety of Fractional-Dose Yellow Fever Vaccination in Autoimmune Rheumatic Diseases and Kinetics of White Blood Cells
  • Abstract Number: 1733
    Should We Perform Exercise Echocardiogram As a Screening Test for Pulmonary Arterial Hypertension (PAH) for All Systemic Sclerosis (SSc) Patients?
  • Abstract Number: 2822
    Should We Prefer Leflunomide to Methotrexate in Combination with Biologics? a Systematic Review and a Meta-Analysis
  • Abstract Number: 1106
    Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Peripheral Blood Mononuclear Cells of Systemic Sclerosis Patients: Correlation with Disease Specific Manifestations
  • Abstract Number: 1047
    Signaling at Adenosine A2A Receptor (A2aR) in Osteoblasts; Crosstalk with Wnt/ β-Catenin Signaling Pathway
  • Abstract Number: 2714
    Significance of Anti-Neutrophil Cytoplasmic Antibodies in Systemic Sclerosis
  • Abstract Number: 428
    Significant Pain Reduction with Oral Methotrexate in Knee Osteoarthritis; Results from a Randomised Controlled Phase III Trial of Treatment Effectiveness
  • Abstract Number: 2593
    Similar Efficacy and Safety of Biosimilar Candidate IBI303 and Reference Products of Adalimumab in Patients with Ankylosing Spondylitis : Results from a Randomized, Double-Blind, Phase III Study
  • Abstract Number: 606
    Similiar Efficacy of Tofacinitib on Disease Activity in Rheumatoid Arthritis Patients with and without Previous Biologicals; Results from the Turkbio Regıstry
  • Abstract Number: 1257
    Simple and Cost-Effective Intervention Doubled the Rate of Osteoporosis Screening in High Risk Rheumatology Patients
  • Abstract Number: 1213
    Simplified Salivary Gland Ultrasonography for Sjögren Syndrome and Sicca Symptoms: Experience from a Single Medical Center in Taiwan
  • Abstract Number: 1533
    Simulating Population Disability Outcomes for Alternative Treatment Pathways in Patients with Active Rheumatoid Arthritis
  • Abstract Number: 1067
    Simulating the Pathogenesis of Arthritis in Vitro By Developing a Human-Based Multicomponent 3D Joint Model
  • Abstract Number: 781
    Simultaneous Identification of Two Biomarkers in ACTIVE LUPUS Nephritis: Autophagy in Treg CELLS and Prolactin Receptors in B Lymphocytes
  • Abstract Number: 2903
    Single Cell Association Testing Identifies an Expanded Th1-Skewed Cytotoxic Effector CD4+ T Cell Subset in Rheumatoid Arthritis
  • Abstract Number: 1897
    Single Cell RNA Expression in Lupus Nephritis Comparing African-American and Caucasian Patients Identifies Differential Expression of Interferon Pathway
  • Abstract Number: 928
    Single Cell RNA-Sequencing of Rheumatoid Synovial Fibroblasts Reveals a Disease-Associated Spatial Gradient Modulated By Inductive Notch Signaling
  • Abstract Number: 77
    Single Nucleotide Polymorphism in the Gene Encoding Peptidylarginine Deiminase 4 Correlates with Reduced Neutrophil Extracellular Traps and Anti-Histone Antibodies in Rheumatoid Arthritis
  • Abstract Number: 110
    Single-Cell RNA-Seq Analysis of ANA+ Healthy and SLE Patients Show Variations in Activated Stress Response and Regulatory Pathways
  • Abstract Number: 1939
    Sirolimus Treatment in Patients with Refractory Rheumatoid Arthritis: A Double-Arm, Open-Label, phase1/2 Trail
  • Abstract Number: 2799
    Sjogren’s Syndrome Minor Salivary Gland CD4+ T Cells Associate with Oral Disease Features and Have a T Follicular Helper-like Transcriptional Profile
  • Abstract Number: 1579
    Sjögren’s Syndrome Is Associated with Reduced Sex Hormone Exposure: A Case-Control Study
  • Abstract Number: 2809
    Skeletal Benefit/Risk of Long-Term Denosumab Therapy: A Virtual Twin Analysis of Fractures Prevented to Skeletal Safety Events Observed
  • Abstract Number: 1718
    Skin Gene Expression Profiling Predicts Longitudinal Modified Rodnan Skin Score Change
  • Abstract Number: 1888
    SLE Among the Leading Causes of Years of Potential Life Lost in Young Women: Population-Based Study, 2000-2015
  • Abstract Number: 1854
    SLE Flares during and after Pregnancy Are Mild and Occur at Similar Rates
  • Abstract Number: 2676
    SLE Patients with No Organ Damage Might Benefit More from Belimumab Treatment
  • Abstract Number: 2655
    SLE-Key® Ruleout Testing in Support of Patient Triage in the Clinical Rheumatology Setting
  • Abstract Number: 2667
    Sledai and Mex-Sledai Glucocorticoid Indices As Predictors of Damage and Mortality in Multinational Multiethnic Latin American Cohort
  • Abstract Number: 2643
    Sledai-2K Responder Index-50 Is Effective in Demonstrating Partial Response in a Phase 2, Randomized Placebo-Controlled Study of Ustekinumab in Patients with Active Systemic Lupus Erythematosus
  • Abstract Number: 1834
    Sleep Apnea and Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry
  • Abstract Number: 144
    Small Molecule Inhibitor of Bcl-6 Reduces the Tfh Population in Peripheral Blood, Splenic Germinal Center and Ankle Joints in a Collagen-Induced Arthritis Mouse Model of RA
  • Abstract Number: 1648
    Smoking Status in Patients with Psoriasis and Psoriatic Arthritis: An Irish Perspective
  • Abstract Number: 2156
    Smoking Status Predicts Earlier SLICC Damage Index Progression in a Large SLE Cohort
  • Abstract Number: 345
    Snap Crackle Pop: Healing the Cracks in Our Referral Process, Helping Pediatric Rheumatology Patients Get Care Sooner
  • Abstract Number: 2372
    Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases – Results of a Global Survey
  • Abstract Number: 2505
    Sociodemographic Factors Are Predictors of Poorer Clinical Outcome Trajectories in Early Rheumatoid Arthritis: Results from the Singapore Early Arthritis Cohort
  • Abstract Number: 2957
    Socioeconomic Differences in Opioid Use By People with Inflammatory Arthritis
  • Abstract Number: 274
    Socioeconomic Disparities in Disease Activity in Patients with Rheumatoid Arthritis
  • Abstract Number: 716
    Soluble CD163 Is a Biomarker Associated with Accelerated Carotid Atheroma in SLE Patients at Otherwise Low Risk for Cardiovascular Disease
  • Abstract Number: 1576
    Soluble Semaphorin 4D/CD100 Is Increased in the Saliva of Sjögren’s Syndrome
  • Abstract Number: 1577
    Soluble Siglec-5 Is a Novel Salivary Biomarker for Primary Sjogren’s Syndrome
  • Abstract Number: 713
    Soluble ST2 and CXCL-10 May Serve As Biomarkers of Diastolic Dysfunction in SLE and Correlate with Disease Activity and Damage
  • Abstract Number: 1134
    Some Is Better Than None: Minimum Physical Activity Threshold to Prevent Disability in Older Adults with Lower Extremity Joint Symptoms
  • Abstract Number: 2376
    Something for Us: Client Perspectives on Lupus Self-Management Programming Using the 5-a Behavior Change Model
  • Abstract Number: 1210
    Sonographic Appearance of Inflammatory Myopathies: Increased Muscle Echointensity and Qualitative Changes
  • Abstract Number: 1641
    Spa-Net: A Disease-Specific Integrated Ehealth System and Quality Registry for Spondyloarthritis in Daily Practice in the Netherlands
  • Abstract Number: 683
    Spanish Validation of the Gepard Questionnaire for the Detection of Psoriatic Arthritis in Argentinean Patients with Psoriasis
  • Abstract Number: 1097
    Spatial-Time Cluster Analysis of SLE Disease Activity
  • Abstract Number: 2187
    Specialist Link Telephone Advice Cost Effectively Enhances Rheumatology Patient Care in Alberta, Canada
  • Abstract Number: 2045
    Specific Anti-Citrullinated Protein Antibodies Profiles Are Associated with Rheumatoid Arthritis Related Interstitial Lung Disease
  • Abstract Number: 1877
    Specific Pneumoproteins Predict Progression of Interstitial Lung Disease in Systemic Sclerosis Patients Undergoing Treatment with Immunosuppression
  • Abstract Number: 1806
    Spinal Cord Involvement in Behcet’s Disease- Experience of a Vasculitis Centre at Silk Road
  • Abstract Number: 768
    Spinal Cord Syndromes Associated with Systemic Lupus Erythematous: Differentiating Lupus Myelitis, Neuromyelitis Optica, and Multiple Sclerosis
  • Abstract Number: 634
    Spinal Mobility Measures Allow Discrimination of Subgroups of Different Activity and Severity in Early Axial Spondyloarthritis
  • Abstract Number: 2924
    Spinal Radiographic Progression in Early Axial Spondyloarthritis: 5-Year Data from the DESIR Cohort
  • Abstract Number: 1228
    Spine Immobilization and Neurological Complications in Vertebral Osteomyelitis: Results from a Multicenter Prospective Observational Study
  • Abstract Number: 2312
    Spontaneous Vertebral Fractures after Denosumab Discontinuation
  • Abstract Number: 2901
    Sputum Neutrophils from Individuals at-Risk for RA Demonstrate Increased Citrullinated Histone H3 Containing Neutrophil Extracellular Traps That Correlate with Sputum Anti-Cyclic Citrullinated Peptide Antibody Levels
  • Abstract Number: 1959
    Stability of DNA Methylation Signature in Primary RA Synovial Fibroblasts Compared with Cultured Fibroblast-like Synoviocytes
  • Abstract Number: 1078
    Standardization of Synovial Biopsies Procedures across Centers: A Consensus Initiative Using a Delphi Survey
  • Abstract Number: 1162
    Standing Balance and Walking Time Among Older Adults with and without Joint Hypermobility: The Johnston County Osteoarthritis Project
  • Abstract Number: 2453
    Staphylococcus Aureus Carriage Rates Are High in Rheumatoid Arthritis Patients on Biologics
  • Abstract Number: 2126
    STAT4 Activation By Type I Interferons Regulates Pathogenic IL-21 and IFN-γ in Lupus
  • Abstract Number: 408
    State or Trait: Pain Catastrophizing and Widespread Pain Following TKR and Their Associations with Pain Relief
  • Abstract Number: 623
    Step-Down-Bridge Versus Tight-Step-up Therapy in Patients with Early Rheumatoid Arthritis Lacking Poor Prognostic Factors: An Economic Point of View
  • Abstract Number: 481
    Stepping It up: The Use of Physical Activity Monitors As an Outcome Measure in Juvenile Myositis
  • Abstract Number: 2197
    Steroid Bolus Leads to a Negative 18f-FDG PET/CT Scan in Large Vessel Vasculitis. Data from a Multicenter Giant Cell Arteritis Cohort Database
  • Abstract Number: 462
    Steroid Use in Pediatric Proliferative Lupus Nephritis
  • Abstract Number: 979
    Stopping Medicines for Inactive Juvenile Idiopathic Arthritis: What Do Patients and Families Consider?
  • Abstract Number: PP07
    Strengthening My Resiliency: How My Interprofessional Healthcare Team and I Improved My Management of Lupus
  • Abstract Number: 1805
    Strong Association of HLA-DRB1*0901 with Japanese Patients with Chronic Progressive Neuro-Behçet’s Disease
  • Abstract Number: 1120
    Strong HLA and Novel Non-HLA Associations Identified By Auto-Antibody Subset Analysis of African Americans with Scleroderma from the Genome Research in African American Scleroderma Patients Cohort
  • Abstract Number: 1287
    Strong Impact of Dysfunctional Variants of ABCG2 on Hyperuricemia and Gout in Children and Adolescents
  • Abstract Number: 865
    Structural and Microstructural Intraarticular Bone Changes at the Metacarpal Heads in Patients with Psoriatic Arthritis Compared to Controls: A HR-pQCT Study
  • Abstract Number: 677
    Structural Damage Characteristics of Patients with Ankylosing Spondylitis in China
  • Abstract Number: 436
    Structural Effects of Intra-Articular Sprifermin in Symptomatic Radiographic Knee Osteoarthritis: A Post-Hoc Analysis of Cartilage Morphology over the 2-Year Treatment-Period of a 5-Year Randomized, Placebo-Controlled, Phase II Study
  • Abstract Number: 2460
    Study of Sixteen Cases of Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Developed in Rheumatoid Arthritis Patients
  • Abstract Number: 1054
    Study of the Metabolic Effect of MSCs on Their Chondroprotective and Regenerative Properties: Modulating Their Metabolism to Improve Their Therapeutic Potential for the Treatment of Osteoarthritis
  • Abstract Number: L02
    Study of Tofacitinib in Refractory Dermatomyositis (STIR): An Open Label Pilot Study in Refractory Dermatomyositis
  • Abstract Number: 309
    Sub-Clinical Disease Activity in the Feet of Patients with Early Rheumatoid Arthritis: What Clinical Assessments Miss
  • Abstract Number: 1650
    Subclinical Atheromatosis and Estimation of Cardiovascular Risk in Patients with Axial Spondyloarthritis
  • Abstract Number: 707
    Subclinical Parameters of Arterial Stiffness and Arteriosclerosis Correlate with QRISK3 in Systemic Lupus Erythematosus
  • Abstract Number: 2378
    Subcutaneous Abatacept in Patients Aged 2–17 Years with Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Results over 24 Months By Juvenile Idiopathic Arthritis Disease Category
  • Abstract Number: 2293
    Subcutaneous Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Analysis of a Monocentric Cohort
  • Abstract Number: 690
    Subcutaneous Secukinumab Provides Sustained Inhibition of Radiographic Progression in Patients with Active Psoriatic Arthritis: 52-Week Results from a Phase 3 Study
  • Abstract Number: 573
    Subcutaneous Tocilizumab in Monotherapy or in Combination with DMARD in Patients with Moderate to Severe Active Rheumatoid Arthritis: Observational Study to Describe Real-World Drug Retention Rate at 12 Months, Interim Analysis
  • Abstract Number: 1770
    Subglottic Stenosis and Endobronchial Disease in Granulomatosis with Polyangiitis
  • Abstract Number: 2299
    Subgroup Analysis of the Effect of Denosumab Compared with Risedronate on Percentage Change in Lumbar Spine Bone Mineral Density at 24 Months in Glucocorticoid-Treated Individuals
  • Abstract Number: 2038
    Subgroups By the Peripheral Immunophenotyping and Different Responses to Biological Dmards in Patients with Rheumatoid Arthritis
  • Abstract Number: 1385
    Subjective Well-Being Among Rheumatoid Arthritis Patients
  • Abstract Number: 1222
    Suboptimal Immunization Coverage Among Rheumatology Patients in Routine Clinical Care
  • Abstract Number: 166
    Superior Sensitivity for Detection of Primary Antiphospholipid Syndrome By a 9-Test Panel in Patients with Deep Venous Thrombosis, Pulmonary Embolism, and Stroke or Transient Ischemic Attack
  • Abstract Number: 1212
    Superiority of Musculoskeletal Ultrasound (MSUS) over Clinical Examination Regarding Detection of Arthritis in Patients with Systemic Sclerosis
  • Abstract Number: 616
    Supplementation of Methotrexate (MTX) with Ticagrelor Therapy Suppresses Disease Activity in Patients with Moderate to Very Active Ra; Further Evidence That Adenosine and Its Receptors Mediate the Anti-Inflammatory Activity of MTX
  • Abstract Number: PP13
    Support Groups and Patient Centred Care; Making a Difference in the Lives of People with Autoimmune and Rheumatic Conditions in Ghana
  • Abstract Number: 66
    Suppression of Inflammatory Arthritis, in Human Paraoxonase 1 Transgenic Mice, Correlates with Upregulation of the Hepatic Glutathione Pathway and Reduction of Bioactive Lipid Mediators
  • Abstract Number: 1000
    Surface Adenosine Monophosphate Deaminase 2 As a Novel Regulator Modifying Ectonucleotidase-Driven Generation of Anti-Inflammatory Extracellular Adenosine
  • Abstract Number: 823
    Survival of Biopsy Proven Giant Cell Arteritis in Northern Italy: Correlation with Clinical, Laboratory and Histopathological Findings
  • Abstract Number: 2609
    Survival of Disease-Modifying Drugs in Patients with Recent Diagnosis of Psoriatic Arthritis in Daily Clinical Practice
  • Abstract Number: 1485
    Survivin Measurements Improve Prediction of Rheumatoid Arthritis Among Patients with Unexplained Arthralgia
  • Abstract Number: 2820
    Sustained Clinical Remission after Discontinuation of Infliximab with a Raising Dose Strategy in Patients with Rheumatoid Arthritis (RRRR study): A Randomized Controlled Trial
  • Abstract Number: 2899
    Sustained Drug-Free Remission in Early RA Following Methotrexate-Based Strategy: Role of the JAK-STAT Pathway
  • Abstract Number: 1659
    Sustained Improvements in Physical Function, Quality of Life, and Work Productivity after Ixekizumab Therapy in Patients with Active Psoriatic Arthritis: 3-Year Results
  • Abstract Number: 1869
    Sustained Improvements in Signs and Symptoms of Active Ankylosing Spondylitis and Reassuring Safety with Secukinumab 300mg: 3-Year Results from a Phase 3 Study
  • Abstract Number: PP02
    Sustained Weight Loss Managed by Multiple Medical Specialists
  • Abstract Number: 179
    Swimming Against the Stream- the Fishbowl Discussion Method As an Interactive Tool for Medical Conferences – Experiences from the 11. European Lupus Meeting
  • Abstract Number: 2533
    Switching Patients with Arthritis from Etanercept (Enbrel) to the Biosimilar Drug, Benepali: A Single- Center Retrospective Observational Study
  • Abstract Number: 322
    Swollen Joint Count Vs. RAPID3: Why a Discrepancy in Remission State?
  • Abstract Number: 1172
    Symptoms Compatible with Osteoarthritis and Self-Reported Osteoarthritis in the Population: Findings from the Canadian Longitudinal Study on Aging
  • Abstract Number: 1218
    Synovial Fluid Culture: Comparison of Two Culture Methods
  • Abstract Number: 2047
    Synovial Fluid Cytokines /Chemokines and Proteins from the Knees of Symptomatic RA and OA Patients Which Correlate with the Magnitude of the Inflammatory Response As Measured By Synovial Fluid WBC Levels
  • Abstract Number: 1232
    Synovial Fluid Profile in Neutropenic Patients with Septic Arthritis
  • Abstract Number: 1053
    Synovial Inflammation Identifies Patients Clusters in Osteoarthritis
  • Abstract Number: 1506
    Synovial Tissue Histopathology Findings in EARLY RA. Is It Usefull? Analysis of the Belgian CAP48 Cohort
  • Abstract Number: 368
    Synovianalysis Using Leukocyte Esterase Reagent Strips
  • Abstract Number: 2906
    Synovitis Focused Ultrasound in Rheumatoid Arthritis: A Joint Reduction Strategy
  • Abstract Number: 2830
    Synovitis in Psoriatic Arthritis and Seronegative Rheumatoid Arthritis: Differential Histological Features
  • Abstract Number: 2221
    Systematic Genetic Analysis of Early-Onset Gout: ABCG2 141K Is the Strongest Predictor
  • Abstract Number: 2345
    Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain
  • Abstract Number: 1756
    Systematic Review of the Clinical Effectiveness of Treatments in Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 1642
    Systematic Screening of Comorbidities Improves Vaccination Rates, Skin Cancer Screening and Vitamin D Supplementation in Patients with Axial Spondyloarthritis: Results of a Prospective, Controlled ,One Year Randomised Trial
  • Abstract Number: 1371
    Systemic Exposure of Triamcinolone Acetonide Following Bilateral Injection of Extended-Release Triamcinolone Acetonide and Standard Triamcinolone in Patients with Bilateral Knee Osteoarthritis
  • Abstract Number: 1290
    Systemic Inflammation and Atherosclerosis in Patients with Gout. Results from the NOR-Gout Study
  • Abstract Number: 395
    Systemic Lupus Erythematosus (SLE) with Inflammatory Myositis
  • Abstract Number: 2932
    Systemic Lupus Erythematosus Biomarkers Identified Using Multi-Omic and Artificial Intelligence Analysis through Interrogative Biology
  • Abstract Number: 2359
    Systemic Lupus Erythematous Outcome Concerns: Identifying Pain As the Major Discrepancy between Rheumatologists and Patients
  • Abstract Number: 1687
    Systemic Lupus Flares Based on BILAG and Sledai Rules Are Inconsistent, but May be Better Understood Using Visual Analogue Scales
  • Abstract Number: 1103
    Systemic Sclerosis Has a Distinct Serum Protein Profile That Correlates with Its Clinical Manifestations
  • Abstract Number: 1440
    Systemic Sclerosis in Pediatric Patients: An Epidemiological Study in a Large Insured Population in the US
  • Abstract Number: 2739
    Systemic Vasculitis: Incidence of Glucocorticoid Related Adverse Events
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Chicago, IL

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.